Registro:

Referencias:

• Williams, S.E., Brown, T.I., Roghanian, A., Sallenave, J.M., SLPI and elafin: One glove, many fingers (2006) Clinical Science, 110, pp. 21-35
• Thompson, R.C., Ohlsson, K., Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase (1986) Proceedings of the National Academy of Sciences of the United States of America, 83, pp. 6692-6696
• Ohlsson, K., Bjartell, A., Lilja, H., Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization (1995) Journal of Andrology, 16, pp. 64-74
• Si-Tahar, M., Merlin, D., Sitaraman, S., Madara, J.L., Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells (2000) Gastroenterology, 118, pp. 1061-1071
• Jacobsen, L.C., Sorensen, O.E., Cowland, J.B., Borregaard, N., Theilgaard-Monch, K., The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils (2008) Journal of Leukocyte Biology, 83, pp. 1155-1164
• Eisenberg, S.P., Hale, K.K., Heimdal, P., Thompson, R.C., Location of the protease-inhibitory region of secretory leukocyte protease inhibitor (1990) The Journal of Biological Chemistry, 265, pp. 7976-7981
• Ambrosi, N., Secretory Leukocyte Peptidase Inhibitor (SLPI) functionality in health and disease (2015) Atlas of Genetics and Cytogenetics in Oncology and Haematology
• Nara, K., Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin (1994) Journal of Biochemistry, 115, pp. 441-448
• Schalkwijk, J., Wiedow, O., Hirose, S., The trappin gene family: Proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core (1999) The Biochemical Journal, 340, pp. 569-577
• Baranger, K., Zani, M.L., Labas, V., Dallet-Choisy, S., Moreau, T., Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate (2011) PloS One, 6, p. e20976
• Bergenfeldt, M., Bjork, P., Ohlsson, K., The elimination of secretory leukocyte protease inhibitor (SLPI) after intravenous injection in dog and man (1990) Scandinavian Journal of Clinical and Laboratory Investigation, 50, pp. 729-737
• Gast, A., Pharmacokinetics and distribution of recombinant secretory leukocyte proteinase inhibitor in rats (1990) The American Review of Respiratory Disease, 141, pp. 889-894
• Birrer, P., Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense (1992) Journal of Applied Physiology, 73, pp. 317-323
• Greene, C.M., McElvaney, N.G., O'Neill, S.J., Taggart, C.C., Secretory leucoprotease inhibitor impairs Toll-like receptor 2-and 4-mediated responses in monocytic cells (2004) Infection and Immunity, 72, pp. 3684-3687
• Bruch, M., Bieth, J.G., Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor (1986) Potent Inhibition of Elastin-bound Elastase by Bronchial Inhibitor. the Biochemical Journal, 238, pp. 269-273
• Salica, J.P., Transglutaminase binding fusion protein linked to SLPI reduced corneal inflammation and neovascularization (2015) BMC Ophthalmology, 15, p. 12
• Park, M.K., Transglutaminase-2 induces N-cadherin expression in TGF-beta1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation (2013) European Journal of Cancer, 49, pp. 1692-1705
• Leu, R.W., Herriott, M.J., Moore, P.E., Orr, G.R., Birckbichler, P.J., Enhanced transglutaminase activity associated with macrophage activation. Possible role in Fc-mediated phagocytosis (1982) Experimental Cell Research, 141, pp. 191-199
• Falasca, L., Transglutaminase type II is involved in the pathogenesis of endotoxic shock (2008) Journal of Immunology, 180, pp. 2616-2624
• Bowness, J.M., Tarr, A.H., Increase in transglutaminase and its extracellular products in response to an inflammatory stimulus by lipopolysaccharide (1997) Molecular and Cellular Biochemistry, 169, pp. 157-163
• Guerrieri, D., Serine leucocyte proteinase inhibitor-treated monocyte inhibits human CD4(+) lymphocyte proliferation (2011) Immunology, 133, pp. 434-441
• Gomez, S.A., Secretory leukocyte protease inhibitor: A secreted pattern recognition receptor for mycobacteria (2009) American Journal of Respiratory and Critical Care Medicine, 179, pp. 247-253
• Muto, J., Kuroda, K., Wachi, H., Hirose, S., Tajima, S., Accumulation of elafin in actinic elastosis of sun-damaged skin: Elafin binds to elastin and prevents elastolytic degradation (2007) The Journal of Investigative Dermatology, 127, pp. 1358-1366
• Taggart, C.C., Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor (2001) The Journal of Biological Chemistry, 276, pp. 33345-33352
• Taggart, C.C., Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding (2005) The Journal of Experimental Medicine, 202, pp. 1659-1668
• Ientile, R., Caccamo, D., Griffin, M., Tissue transglutaminase and the stress response (2007) Amino Acids, 33, pp. 385-394
• Thomas-Ecker, S., Alteration in the gene expression pattern of primary monocytes after adhesion to endothelial cells (2007) Proceedings of the National Academy of Sciences of the United States of America, 104, pp. 5539-5544
• Akimov, S.S., Belkin, A.M., Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin (2001) Blood, 98, pp. 1567-1576
• Matic, I., Characterization of transglutaminase type II role in dendritic cell differentiation and function (2010) Journal of Leukocyte Biology, 88, pp. 181-188
• Shaw, L., Wiedow, O., Therapeutic potential of human elafin (2011) Biochemical Society Transactions, 39, pp. 1450-1454
• Huntington, J.A., Serpin structure, function and dysfunction (2011) Journal of Thrombosis and Haemostasis: JTH, 9, pp. 26-34
• Maffia, P.C., Neutrophil elastase converts human immature dendritic cells into transforming growth factor-beta1-secreting cells and reduces allostimulatory ability (2007) The American Journal of Pathology, 171, pp. 928-937
• Kawai, Y., Wada, F., Sugimura, Y., Maki, M., Hitomi, K., Transglutaminase 2 activity promotes membrane resealing after mechanical damage in the lung cancer cell line A549 (2008) Cell Biology International, 32, pp. 928-934

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------